Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
A longitudinal cohort study of sexually active women 18-30 years of age was conducted to identify variables associated with the acquisition of herpes simplex virus type 2 (HSV-2) infections. Six hundred seventy HSV-2-seronegative women were followed up at 4-month intervals for 1 year; acquisition of HSV-2 antibodies was detected in 32 of these women. Black race, < or =12 years of education, having a new sex partner, and bacterial vaginosis (BV) were associated with HSV-2 seroconversion on univariate analysis. Antecedent HSV-1 infection was not protective against HSV-2 acquisition. After controlling for other identified risk factors in multivariable models, the diagnosis of BV remained associated with an increased risk of acquiring HSV-2 infection (hazard ratio, 2.1; 95% confidence interval, 1.0-4.5; P=.05). In this study, the population attributable risk of BV for HSV-2 seroconversion was 21%. Additional studies are needed to determine whether screening and treatment of BV could reduce susceptibility to the acquisition of HSV-2 in women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As the normal vaginal microbiota is protective against the acquisition of STI,26–29 and HIV,30 31 menstrual cups may have the potential to reduce the incidence of such infections in vulnerable girls and the spread to their partners.”
Citations
Cites
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,331 · cited 1×
“Vaginal smears were Gram-stained and evaluated for BV according to a standardized 0–10-point scoring system [10].”
MethodSelf-citationThe social organization of sexuality: sexual practices in the United States
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4802a · Cited by 2,890
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371601 · Cited by 1,189
Martin, H. L., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B., Mandaliya, K., Ndinya‐Achola, J. O., Bwayo, J., & Kreiss, J. (1999) · The Journal of Infectious Diseases · doi:10.1086/315127 · Cited by 891
Self-citationHIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
Sewankambo, N., Gray, R. H., Wawer, M. J., Paxton, L., McNairn, D., Wabwire-Mangen, F., Serwadda, D., Li, C., Kiwanuka, N., Hillier, S. L., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01063-5 · Cited by 655 · cited 1×
“Because the prevalence of BV among women in some communities can be as high as 50% [14], it seems likely that more-comprehensive screening and appropriate treatment of BV would reduce susceptibility to the acquisition of HSV-2 among women.”
BackgroundSelf-citationBacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV
Taha, T. E., Hoover, D. R., Dallabetta, G. A., Kumwenda, N. I., Mtimavalye, L. A. R., Yang, L.-P., Liomba, G. N., Broadhead, R. L., Chiphangwi, J. D., & Miotti, P. G. (1998) · AIDS · doi:10.1097/00002030-199813000-00019 · Cited by 634
Diffusion of Macromolecules and Virus-Like Particles in Human Cervical Mucus
Olmsted, S. S., Padgett, J. L., Yudin, A. I., Whaley, K. J., Moench, T. R., & Cone, R. A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75844-4 · Cited by 544 · cited 1×
“In vitro, cervical mucus has demonstrated the ability to trap HSV in its viscous gel [17].”
BackgroundAshley, R. L., Militoni, J., Lee, F., Nahmias, A., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 541 · cited 1×
“For samples in which antibodies to HSV-2 were found by ELISA (and on serum samples from the visits that immediately preceded and followed ELISA seroconversion), Western blot (WB) analysis was performed by the University of Washington Virology Laboratory (Seattle), using methods described elsewhere [12].”
MethodA Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2
Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 510 · cited 1×
“Likewise, the Chiron HSV Vaccine Study Group found that previous HSV-1 infection increased the likelihood of asymptomatic HSV-2 seroconversion but did not reduce the rate of HSV-2 acquisition [23].”
Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections
Wald, A., Zeh, J., Selke, S., Ashley, R. L., & Corey, L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509213331205 · Cited by 507 · cited 1×
“sociated with higher rates of vaginal shedding of virus [13].”
Background
Research works printed but not linked: 3
- Mindel, 1996, Scandinavian journal of infectious diseases. Supplementum, 100, 27
- Mertz, 1992, Annals of Internal Medicine, 116, 197, 10.1059/0003-4819-116-3-197 · doi:10.1059/0003-4819-116-3-197
- Siegel, 1992, JAMA, 268, 1702, 10.1001/jama.1992.03490130090036 · doi:10.1001/jama.1992.03490130090036
Cited by
Items 101–200 of 415
Prevalence of bacterial vaginosis among women in Delhi, India.
Bhalla, P., Chawla, R., Garg, S., Singh, M. M., Raina, U., Bhalla, R., & Sodhanit, P. (2007) · PubMed · Cited by 100
Risk Factors for Cervicitis among Women with Bacterial Vaginosis
Marrazzo, J. M., Wiesenfeld, H. C., Murray, P. J., Busse, B., Meyn, L. A., Krohn, M. A., & Hillier, S. L. (2006) · The Journal of Infectious Diseases · doi:10.1086/500149 · Cited by 99
“Because the presence of BV may increase the risk of acquiring genital herpes simplex virus type 2 infection [54], this association re-”
BackgroundSelf-citationEffects of vaginal lactobacilli in Chlamydia trachomatis infection
Mastromarino, P., Pietro, M. D., Schiavoni, G., Nardis, C., Gentile, M., & Sessa, R. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.04.006 · Cited by 102
Human Milk Inactivates Pathogens Individually, Additively, and Synergistically
Isaacs, C. E. (2005) · Journal of Nutrition · doi:10.1093/jn/135.5.1286 · Cited by 95
The vaginal eukaryotic DNA virome and preterm birth
Wylie, K. M., Wylie, T., Cahill, A. G., Macones, G. A., Tuuli, M. G., & Stout, M. J. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.04.048 · Cited by 94
Baisley, K., Changalucha, J., Weiss, H. A., Mugeye, K., Everett, D., Hambleton, I., Hay, P., Ross, D., Tanton, C., Chirwa, T., et al. (2009) · Sexually Transmitted Infections · doi:10.1136/sti.2008.035543 · Cited by 93
“[5,6,8,23,241] The higher BV prevalence observed in our study is likely to reflect the fact that our population was HSV-2 seropositive, since a strong association between BV and HSV-2 has been observed in many studies.[5,7,23]”
Mucosal Immunity in the Female Genital Tract, HIV/AIDS
Machado, J. R., da Silva, M. V., Cavellani, C. L., dos Reis, M. A., Monteiro, M. L. G. D. R., Teixeira, V. D. P. A., & Corrêa, R. R. M. (2014) · BioMed Research International · doi:10.1155/2014/350195 · Cited by 93
“On the other hand, coinfection of CD4 T-cells by HIV and HSV results in a rapid unidirectional replication of HIV, whereas the acquisition, reactivation, and shedding of HSV-2 are facilitated by disturbances in the vaginal flora resulting in bacterial vaginosis [271, 272].”
BackgroundSpermicidal Activity of the Safe Natural Antimicrobial Peptide Subtilosin
Sutyak, K. E., Anderson, R. A., Dover, S. E., Feathergill, K. A., Aroutcheva, A. A., Faro, S., & Chikindas, M. L. (2008) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2008/540758 · Cited by 89
Allsworth, J. E., Lewis, V. A., & Peipert, J. F. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181788301 · Cited by 93
Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa
Oh, J. E., Kim, B.-C., Chang, D.-H., Kwon, M., Lee, S. Y., Kang, D., Kim, J. Y., Hwang, I., Yu, J.-W., Nakae, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518589113 · Cited by 84
“Although several studies in humans have described the association between bacterial vaginosis and genital herpes simplex virus (HSV) infection (10, 11), the mechanisms through which dysbiosis modulates antiviral immunity to HSV infection remain unclear.”
BackgroundSexually Transmitted Infections Among Women Who Have Sex With Women
Gorgos, L. M., & Marrazzo, J. M. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir697 · Cited by 95
“The calculated population attributable risk of BV for HSV-2 seroconversion was 21% [23].”
BackgroundVaginal Lactobacillus Inhibits HIV-1 Replication in Human Tissues Ex Vivo
Palomino, R. A. Ñ., Zicari, S., Vanpouille, C., Vitali, B., & Margolis, L. B. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00906 · Cited by 88
“…away from Lactobacillus dominance, are associated with bacterial vaginosis and increased risks of acquisition of sexually transmitted infections (Cherpes et al., 2003; Wiesenfeld et al., 2003), in particular HIV (Taha et al., 1998; Atashili et al., 2008; Nardis et al., 2013; Mirmonsef and…”
BackgroundSpear, G. T., Gilbert, D. Z., Sikaroodi, M., Doyle, L. A., Green, L., Gillevet, P. M., LANDAY, A. L., & Veazey, R. S. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2009.0166 · Cited by 82
Factors Associated with Absence of H2O2‐ProducingLactobacillusamong Women with Bacterial Vaginosis
Beigi, R. H., Wiesenfeld, H. C., Hillier, S. L., Straw, T., & Krohn, M. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/428288 · Cited by 87
“infection [11–14].”
BackgroundSelf-citationManhanzva, M. T., Abrahams, A. G., Gamieldien, H., Froissart, R., Jaspan, H. B., Jaumdally, S. Z., Barnabas, S. L., Dabee, S., Bekker, L., Gray, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62184-8 · Cited by 87
Lactobacilli and Their Probiotic Effects in the Vagina of Reproductive Age Women
Pendharkar, S., Skafte-Holm, A., Simsek, G., & Haahr, T. (2023) · Microorganisms · doi:10.3390/microorganisms11030636 · Cited by 67
Mastromarino, P., Cacciotti, F., Masci, A., & Mosca, L. (2011) · Anaerobe · doi:10.1016/j.anaerobe.2011.04.022 · Cited by 77
“The acquisition of HSV-2 infection has been associated with BV [4] and abnormal vaginal flora has been identified as a risk factor for genital tract shedding of HSV-2 in women [5].”
BackgroundVaginal microbiota and viral sexually transmitted diseases.
Nardis, C., Mosca, L., & Mastromarino, P. (2013) · PubMed · doi:10.7416/ai.2013.1946 · Cited by 76
“and incidence of many viral sexually transmitted infections such as human immunodeficiency virus (HIV), human papillomavirus (HPV), herpes simplex virus (HSV) and cytomegalovirus (CMV) infection (36, 40, 45-56, 59, 63-70, 74, 77-79).”
BackgroundSchwebke, J. R. (2005) · The Journal of Infectious Diseases · doi:10.1086/462430 · Cited by 76
“sociated with abnormal vaginal flora [27, 28].”
Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium
Lokken, E. M., Balkus, J. E., Kiarie, J. N., Hughes, J. P., Jaoko, W. G., Totten, P. A., McClelland, R. S., & Manhart, L. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx043 · Cited by 78
Bradshaw, C. S., Plummer, E. L., Muzny, C. A., Mitchell, C. M., Fredricks, D. N., Herbst‐Kralovetz, M. M., & Vodstrcil, L. A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00626-1 · Cited by 77
“It is associated with serious obstetric and gynaecologic sequelae such as preterm birth and spontaneous abortion 12 , increased risk of HIV infection and sexually transmitted infections (STIs) 13–15 and has negative effects on quality of life 16,17 .”
Abdelmaksoud, A. A., Koparde, V. N., Sheth, N. U., Serrano, M. G., Glascock, A. L., Fettweis, J. M., Strauss, J. F., Buck, G. A., & Jefferson, K. K. (2016) · Microbiology · doi:10.1099/mic.0.000238 · Cited by 70
Bacterial vaginosis and surgical site infections
Soper, D. E. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.09.002 · Cited by 75
Izadifar, Z., Cotton, J., Chen, S., Bustos, N. A., Horvath, V., Stejskalová, A., Wu, C. M., Gulati, A., LoGrande, N., Budnik, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48910-0 · Cited by 72
Mirmonsef, P., Gilbert, D. Z., Veazey, R. S., Wang, J., Kendrick, S. R., & Spear, G. T. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0071 · Cited by 71
“1, 3, and 4) and R (Fig.”
Bacterial vaginosis: a primer for clinicians
Reiter, S., & Spadt, S. K. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2019.1546534 · Cited by 84
“vaginalis [71], HIV [72], and herpes simplex type 2 [50], the overall potential benefits of treating women with asymptomatic BV to prevent the transmission of sexually transmitted diseases remains the subject of debate.”
BackgroundReid, G., Burton, J., Hammond, J.-A., & Bruce, A. W. (2004) · Journal of Medicinal Food · doi:10.1089/1096620041224166 · Cited by 73
“BV can be associated with endometritis, pelvic inflammatory 7 8,9 disease 10,11 a yeast vaginitis, when in fact they may actually be suffering from BV.”
Vaginal practices, microbicides and HIV: what do we need to know?
Hilber, A. M., Chersich, M., van de Wijgert, J. H. H. M., Rees, H., & Temmerman, M. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2007.028597 · Cited by 84
Stanberry, L. R., Rosenthal, S. L., Mills, L., Succop, P., Biro, F. M., Morrow, R. A., & Bernstein, D. I. (2004) · Clinical Infectious Diseases · doi:10.1086/425307 · Cited by 78
Ovarian cycling and reproductive state shape the vaginal microbiota in wild baboons
Miller, E. A., Livermore, J. A., Alberts, S. C., Tung, J., & Archie, E. A. (2017) · Microbiome · doi:10.1186/s40168-017-0228-z · Cited by 68
Holm, J. B., France, M., Ma, B., McComb, E. J., Robinson, C. K., Mehta, A., Tallon, L. J., Brotman, R. M., & Ravel, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00117 · Cited by 68
“As its name suggests, this bacterium is often associated with bacterial vaginosis (BV), a common vaginal disorder that has been shown to increase a woman’s risk for HIV, Chlamydia trachomatis, and Neisseria gonorrhoeae infections as well as preterm birth.”
BackgroundProbiotics: potential to prevent HIV and sexually transmitted infections in women
Bolton, M., van der Straten, A., & Cohen, C. R. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31815b017a · Cited by 67
Emerging Sexual Health Issues Among Women Who Have Sex with Women
Marrazzo, J. M., & Gorgos, L. M. (2012) · Current Infectious Disease Reports · doi:10.1007/s11908-012-0244-x · Cited by 68
Bacterial vaginosis and human immunodeficiency virus infection
Spear, G. T., John, E. S., & Zariffard, M. R. (2007) · AIDS Research and Therapy · doi:10.1186/1742-6405-4-25 · Cited by 76
“There is also evidence, some of it through cross-sectional studies, that the presence of BV increases the risk of infection with several other sexually transmitted infections (STI), including herpes simplex virus type 2 (HSV-2), gonorrhea, Trichomonas vaginalis and Chlamydia trachomatis [23-25].”
ResultSiqueira, J. D., Curty, G., Deng, X., Hofer, C. B., Machado, E. S., Seuánez, H. N., Soares, M. A., Delwart, E., & Soares, E. A. (2019) · Viruses · doi:10.3390/v11050422 · Cited by 64
“Recent studies have shown that CSTs III and IV are associated with a higher prevalence of HIV, HPV, and HSV-2 infections [35,90].”
BackgroundConceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota Transplant
DeLong, K., Bensouda, S., Zulfiqar, F., Zierden, H. C., Hoang, T., Abraham, A. G., Coleman, J. S., Cone, R. A., Gravitt, P. E., Hendrix, C. W., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00306 · Cited by 66
“Diversity in the vaginal microbiota and lack of dominance by Lactobacillus species can be described clinically as bacterial vaginosis (BV), a condition that has been linked to increased risk of sexually transmitted infection acquisition and transmission (Cherpes et al., 2003; Wiesenfeld et al., 2003; Allsworth et al.,…”
BackgroundCorrelates of the molecular vaginal microbiota composition of African women
Gautam, R., Borgdorff, H., Jespers, V., Francis, S. C., Verhelst, R., Mwaura, M., Delany-Moretlwe, S., Ndayisaba, G., Kyongo, J. K., Hardy, L., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0831-1 · Cited by 58
“in the vagina, such as Candida species, Trichomonas vaginalis, and other sexually transmitted pathogens [3-6].”
BackgroundResultLactobacillus iners and Genital Health: Molecular Clues to an Enigmatic Vaginal Species
Holm, J. B., Carter, K. A., Ravel, J., & Brotman, R. M. (2023) · Current Infectious Disease Reports · doi:10.1007/s11908-023-00798-5 · Cited by 63
Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
Tamarelle, J., Ma, B., Gajer, P., Humphrys, M., Terplan, M., Mark, K., Thiébaut, A. C. M., Forney, L. J., Brotman, R. M., Delarocque‐Astagneau, E., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz499 · Cited by 61
Rebbapragada, A., Howe, K. L., Wachihi, C., Pettengell, C., Sunderji, S., Huibner, S., Ball, T. B., Plummer, F. A., Jaoko, W. G., & Kaul, R. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318189a7ca · Cited by 60
“Alternatively, it might be an indirect effect, perhaps, due to the recruitment of activated CD4 T cells with subsequent increased HIV replication in the genital mucosa or due to interactions between BVand herpes simplex virus type 2 (HSV-2).(6,7) We hypothesized that the well-documented association of BV with increase…”
BackgroundZiklo, N., Huston, W. M., Taing, K., Katouli, M., & Timms, P. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0903-4 · Cited by 60
Kriebs, J. M. (2008) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2008.01.010 · Cited by 63
Amato, V., Papaleo, E., Pasciuta, R., Viganò, P., Ferrarese, R., Clementi, N., Sanchez, A. M., Quaranta, L., Burioni, R., Ambrosi, A., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz525 · Cited by 65
“Besides representing a risk factor for acquiring sexually transmitted infections [4, 5], BV is known to be among the causes of adverse pregnancy outcome [6] and pelvic inflammatory disease [7].”
Bacterial vaginosis and host immunity
John, E. S., Mares, D., & Spear, G. T. (2007) · Current HIV/AIDS Reports · doi:10.1007/s11904-007-0004-y · Cited by 65
“Recently, increased risk of infection by herpes simplex virus type 2 has also been noted in women with BV [ 23 ].”
BackgroundDiagnosis of Vaginal Discharge by Wet Mount Microscopy: A Simple and Underrated Method
Mylonas, I., & Bergauer, F. (2011) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31822bdf31 · Cited by 58
The rationale for probiotics in female urogenital healthcare.
Reid, G., Burton, J. P., & Devillard, E. (2004) · Medscape general medicine · Cited by 58
Antiviral effects of Lactobacillus crispatus against HSV-2 in mammalian cell lines
Mousavi, E., Makvandi, M., Teimoori, A., Ataei, A., Ghafari, S., & Samarbafzadeh, A. (2017) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.07.010 · Cited by 57
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections
Avitabile, E., Menotti, L., Croatti, V., Giordani, B., Parolin, C., & Vitali, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179168 · Cited by 57
“…study admittedly did not consider the effect of anti-BV treatments on HSV-2 replication and shedding, but, based on previous results in which women with BV showed an increased risk of HSV-2 infection [224,228], a role of the healthy microbiota in protecting from HSV-2 primary infection is expected.”
BackgroundResultBrabin, L., Roberts, S. A., Fairbrother, E., Mandal, D., Higgins, S. P., Chandiok, S., Wood, P., Barnard, G., & Kitchener, H. C. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2005.014621 · Cited by 63
Weathering the storm; a review of pre-pregnancy stress and risk of spontaneous abortion
Frazier, T., HOGUE, C. J. R., Bonney, E. A., Yount, K. M., & Pearce, B. D. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.03.001 · Cited by 63
Chohan, V., Baeten, J. M., Benki, S., Graham, S. M., Lavreys, L., Mandaliya, K. N., Ndinya‐Achola, J. O., Jaoko, W. G., Overbaugh, J. M., & McClelland, R. S. (2009) · Sexually Transmitted Infections · doi:10.1136/sti.2009.036103 · Cited by 53
McClelland, R. S., Balkus, J. E., Lee, J., Anzala, O., Kimani, J., Schwebke, J., Bragg, V., Lensing, S., & Kavak, L. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu818 · Cited by 49
“Bacterial vaginosis has also been associated with herpes simplex virus type-2 (HSV-2) [10–12], human papilloma virus (HPV) [13], Neisseria gonorrhoeae [14], Chlamydia trachomatis [14, 15], and TV [8, 15–17].”
BackgroundMujugira, A., Magaret, A., Celum, C., Baeten, J. M., Lingappa, J. R., Morrow, R. A., Fife, K. H., Delany‐Moretlwe, S., de Bruyn, G., Bukusi, E. A., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit333 · Cited by 56
“This practice may increase HSV-2 susceptibility directly, by disrupting the vaginal epithelium, or indirectly, by facilitating the occurrence of bacterial vaginosis, which may increase the risk of HSV-2 acquisition [26].”
BackgroundProtection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections
Tuddenham, S., Ravel, J., & Marrazzo, J. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa762 · Cited by 57
Dimitonova, S. P., Danova, S. T., Serkedjieva, J., & Bakalov, B. (2007) · Anaerobe · doi:10.1016/j.anaerobe.2007.08.003 · Cited by 53
Understanding the Burden and Management of Urinary Tract Infections in Women
Baimakhanova, B. B., САДАНОВ, А. К., Trenozhnikova, L. P., Balgimbaeva, A. S., Baimakhanova, G. B., Orasymbet, S., Tleubekova, D., Amangeldi, A., TURLYBAYEVA⃰, Z. Z., Nurgaliyeva, Z. Z., et al. (2025) · Diseases · doi:10.3390/diseases13020059 · Cited by 52
“After menopause, the decline in estrogen levels raises the vaginal pH above 4.5, reducing lactobacilli and allowing gut bacteria, such as E. coli , to colonize the vagina more easily [93].”
InfluentialThe Role of Co-Infections in Mother-to-Child Transmission of HIV
King, C. C., Ellington, S., & Kourtis, A. P. (2013) · Current HIV Research · doi:10.2174/157016213804999258 · Cited by 62
Evaluation of vaginal pH for detection of bacterial vaginosis.
Rajkumar, H., Ramalaxmi, B. A., Swetha, E., Balakrishna, N., & Mastromarino, P. (2013) · PubMed Central · Cited by 64
Cherpes, T. L., Meyn, L. A., & Hillier, S. L. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000151414.64297.46 · Cited by 51
Self-citationRole of probiotics in urogenital healthcare
Waigankar, S., & Patel, V. (2011) · Journal of Mid-life Health · doi:10.4103/0976-7800.83253 · Cited by 47
“Multiple studies have also shown that the absence or depletion of Lactobacilli in the vagina, associated with overgrowth of anerobic pathogens causing BV, results in significantly increased risk for HIV, gonorrhea, chlamydia, and herpes simplex virus infections.[37-41]”
BackgroundSpear, G. T., Gilbert, D., Landay, A. L., Zariffard, R., French, A. L., Patel, P., & Gillevet, P. M. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00973-10 · Cited by 47
“Colonization by lactobacilli is also associated with lower rates of infection with several sexually transmitted diseases (1, 6, 7, 19, 24, 28).”
BackgroundConnecting the Dots: Translating the Vaginal Microbiome Into a Drug
Lagenaur, L. A., Hemmerling, A., Chiu, C. Y., Miller, S. A., Lee, P. P., Cohen, C. R., & Parks, T. P. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa676 · Cited by 54
“Several negative sequelae accompany proinflammatory dysbiosis, such as increased risk of sexually transmitted infections (STIs) [21, 22], including human immunodeficiency virus (HIV) [23], pelvic inflammatory disease [24], preterm birth [25], and enhanced progression of cervical cancer human papillomavirus (HPV) [26].”
BackgroundCrucitti, T., Hardy, L., van de Wijgert, J. H. H. M., Agaba, S. K., Buyze, J., Kestelyn, E., Delvaux, T., Mwambarangwe, L., Baetselier, I. D., Jespers, V., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201003 · Cited by 49
Thibault, S., Fromentin, R., Tardif, M. R., & Tremblay, M. J. (2009) · Retrovirology · doi:10.1186/1742-4690-6-42 · Cited by 55
“It should be noted that BV is associated with an increased risk for contracting HIV-1 infection and several other sexually transmitted infections, including herpes simplex virus type 2 [81-83].”
BackgroundBacterial vaginosis: A problematic infection from both a perinatal and neonatal perspective
Denney, J. M., & Culhane, J. F. (2009) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2009.01.008 · Cited by 60
Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
Ravel, J., Gajer, P., Fu, L., Mauck, C. K., Koenig, S. S. K., Sakamoto, J. M., Motsinger‐Reif, A. A., Doncel, G. F., & Zeichner, S. L. (2012) · mBio · doi:10.1128/mbio.00370-12 · Cited by 47
Current thinking on genital herpes
Hofstetter, A. M., Rosenthal, S. L., & Stanberry, L. R. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000029 · Cited by 46
“without HSV-1 antibody, suggesting a lack of protective immunity [72,73,78].”
BackgroundSecnidazole: Next-Generation Antimicrobial agent for Bacterial Vaginosis Treatment
Nyirjesy, P., & Schwebke, J. R. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0270 · Cited by 46
Effects of Long-Term Use of Nonoxynol-9 on VaginalFlora
Schreiber, C. A., Meyn, L. A., Creinin, M. D., Barnhart, K. T., & Hillier, S. L. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000189094.21099.4a · Cited by 46
“Cochrane Database Syst Rev 2002; (4):CD003939.”
Self-citationMoss, J. A., Srinivasan, P., Smith, T. J., Butkyavichene, I., Lopez, G., Brooks, A. A., Martin, A. M., Dinh, C. T., Smith, J. M., & Baum, M. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02871-14 · Cited by 45
“Vaginal microbiomes dominated by lactobacilli are known to play a central role in maintaining vaginal health in women (35–37) and are strongly associated with reduced risks of infections by sexually transmitted pathogens, including HIV-1 (38, 39) and herpes simplex virus 2 (HSV-2) (40).”
BackgroundReznichenko, H., Henyk, N. I., MALYUK, V. V., Khyzhnyak, T., Tynna, Y., Filipiuk, I., Veresnyuk, N. S., Zubrytska, L., Quintens, J., Richir, K., et al. (2020) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000518 · Cited by 45
Bacterial vaginosis: many questions - any answers?
O??Brien, R. F. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000170516.35272.45 · Cited by 44
Bacterial vaginosis: A state of microbial dysbiosis
Mondal, A. S., Sharma, R., & Trivedi, N. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100082 · Cited by 44
Gardnerella Species and Their Association With Bacterial Vaginosis
Munch, M. M., Strenk, S. M., Srinivasan, S., Fiedler, T. L., Proll, S. C., & Fredricks, D. N. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae026 · Cited by 45
“BV has been associated with a wide range of negative health outcomes such as increased risk of preterm birth [4], acquisition of sexually transmitted infections [5, 6] and pelvic inflammatory disease [7].”
BackgroundAssociation between Semen Exposure and Incident Bacterial Vaginosis
Gallo, M. F., Warner, L., King, C. C., Sobel, J. D., Klein, R. S., Cu‐Uvin, S., Rompalo, A. M., & Jamieson, D. J. (2011) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2011/842652 · Cited by 48
“The HIV Epidemiology Research Study Group consists of the following: Robert S. Klein, MD, Ellie Schoenbaum, MD, Julia Arnsten, MD, MPH, Robert D. Burk, MD, Chee Jen Chang, PhD, Penelope Demas, PhD, and Andrea Howard, MD, MSc, from Montefiore Medical Center and the Albert Einstein College of Medicine; Paula Schuman, MD…”
BackgroundInfluentialBrotman, R. M., Erbelding, E. J., Jamshidi, R., Klebanoff, M. A., Zenilman, J. M., & Ghanem, K. G. (2007) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2006.11.009 · Cited by 44
Cruciani, F., Brigidi, P., Calanni, F., Lauro, V., Tacchi, R., Donders, G. G. G., Peters, K., Guaschino, S., & Vitali, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00061-12 · Cited by 43
“Furthermore, in this state of diminished colonization resistance, BV renders women particularly vulnerable to the acquisition of HIV and other sexually transmitted pathogens, such as Chlamydia trachomatis, Neisseria gonorrhoeae, and herpes simplex virus type 2 infection (7, 25, 44).”
BackgroundQi, F., Fan, S., Fang, C., Ge, L., Lyu, J., Huang, Z., Zhao, S., Zou, Y., Huang, L.-T., Liu, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125239 · Cited by 42
Characterization of the vaginal microflora in health and disease.
Datcu, R. (2014) · PubMed · Cited by 53
Comparison of Hay’s Criteria with Nugent’s Scoring System for Diagnosis of Bacterial Vaginosis
Chawla, R., Bhalla, P., Chadha, S., Grover, S., & Garg, S. (2013) · BioMed Research International · doi:10.1155/2013/365194 · Cited by 36
The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
Seta, F. D., Hoffmann, R., Campisciano, G., Comar, M., Verstraelen, H., Vieira‐Baptista, P., Ventolini, G., & Lev‐Sagie, A. (2021) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000645 · Cited by 46
“Other studies found an association between lactobacilli absence and increased risk of HIV-1 infection as well as herpes simplex virus (HSV) 2 seroconversion.(61,62) Concomitant genital HSV-2 infection increase the transmission of HIV(83) and, in turn,”
BackgroundThoma, M. E., Gray, R. H., Kiwanuka, N., Aluma, S., Wang, M.-C., Sewankambo, N., & Wawer, M. J. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.07.002 · Cited by 42
Kerubo, E., Laserson, K. F., Otecko, N., Odhiambo, C., Mason, L., Nyothach, E., Oruko, K. O., Bauman, A., Vulule, J., Zeh, C., et al. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052371 · Cited by 40
Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis
Cherpes, T. L., Marrazzo, J. M., Cosentino, L. A., Meyn, L. A., Murray, P. J., & Hillier, S. L. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2007.026625 · Cited by 46
Self-citationNarayankhedkar, A., Hodiwala, A., & Mane, A. (2015) · Journal of Sexually Transmitted Diseases · doi:10.1155/2015/817092 · Cited by 37
“It is associated with an increased vaginal pH and replacement of vaginal Lactobacilli with Gardnerella vaginalis and anaerobic Gram-negative rods [3].”
BackgroundPerceived stress and incident sexually transmitted infections in a prospective cohort
Turpin, R., Brotman, R. M., Miller, R. S., Klebanoff, M. A., He, X., & Slopen, N. B. (2019) · Annals of Epidemiology · doi:10.1016/j.annepidem.2019.01.010 · Cited by 39
Joyisa, N., Moodley, D., Nkosi, T., Talakgale, R., Sebitloane, M., Naidoo, M., & Karim, Q. A. (2019) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2019/7808179 · Cited by 42
Current vaccine approaches and emerging strategies against herpes simplex virus (HSV)
Wijesinghe, V. N., Farouk, I. A., Zabidi, N. Z., Puniyamurti, A., Choo, W. S., & Lal, S. K. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1960162 · Cited by 40
“Bacterial vaginosis develops when there is a disruption to the normal vaginal pH due to the replacement of vaginal lactobacilli with Gardnerella vaginalis and other anaerobic bacterial species [53,54].”
BackgroundPossible Therapeutic Mechanisms and Future Perspectives of Vaginal Microbiota Transplantation
Tuniyazi, M., Li, S., Fu, Y., Hu, X., & Zhang, N. (2023) · Microorganisms · doi:10.3390/microorganisms11061427 · Cited by 38
Biological control of vaginosis to improve reproductive health.
Mastromarino, P., Hemalatha, R., Barbonetti, A., Cinque, B., Cifone, M. G., Tammaro, F., & Francavilla, F. (2014) · PubMed Central · Cited by 38
Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial
Hillier, S. L., Nyirjesy, P., Waldbaum, A. S., Schwebke, J. R., Morgan, F. G., Adetoro, N., & Braun, C. J. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002135 · Cited by 37
Self-citationSpear, G. T., Kersh, E. N., Guenthner, P. C., Vishwanathan, S. A., Gilbert, D. Z., Zariffard, M. R., Mirmonsef, P., LANDAY, A. L., Zheng, L., & Gillevet, P. M. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0382 · Cited by 37
Microbiota and Recurrent Pregnancy Loss (RPL); More than a Simple Connection
Garmendia, J. V., Sanctis, C. V. D., Hajdúch, M., & Sanctis, J. B. D. (2024) · Microorganisms · doi:10.3390/microorganisms12081641 · Cited by 35
The Barrier to HIV Transmission Provided by Genital Tract Lactobacillus Colonization
Mirmonsef, P., & Spear, G. T. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12232 · Cited by 35
Gallo, M. F., Warner, L., Macaluso, M., Stone, K. M., Brill, I. K., Fleenor, M. E., Hook, E. W., Austin, H. D., Lee, F. K., & Nahmias, A. J. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31816fcaf8 · Cited by 35
Ethnic disparity in diagnosing asymptomatic bacterial vaginosis using machine learning
Celeste, C., Ming, D., Broce, J., Ojo, D. P., Drobina, E., Louis‐Jacques, A. F., Gilbert, J. E., Fang, R., & Parker, I. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00953-1 · Cited by 34
“Bacterial vaginosis (BV) is a common vaginal syndrome among women of reproductive age and is associated with a multitude of adverse complications including the risk of preterm labor 1 , pelvic in fl ammatory disease 2 – 4 , STIs 5,6 , and HIV infection 7,8 .”
Francis, S. C., Looker, C., Vandepitte, J., Bukenya, J. N., Mayanja, Y., Nakubulwa, S. K., Hughes, P. J., Hayes, R., Weiss, H. A., & Grosskurth, H. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052160 · Cited by 37
Evidence of a TH1-Shift of Local Vaginal Inflammatory Response During Bacterial Vaginosis
Anton, G., Rid, J., Mylonas, I. G., Friese, K., & Weissenbacher, E. R. (2008) · Infection · doi:10.1007/s15010-007-7152-2 · Cited by 33
“An association between BV and HIV infections has been recently reported [29, 30], although the precise role of this coinfection is still quite unclear.”
BackgroundBacterial Vaginosis: A Clinical Update with a Focus on Complementary and Alternative Therapies
Falconi‐McCahill, A. (2019) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.13013 · Cited by 33
Hugerth, L. W., Pereira, M., Zha, Y., Seifert, M., Kaldhusdal, V., Boulund, F., Krog, M. C., Bashir, Z., Hamsten, M., Fransson, E., et al. (2020) · mSphere · doi:10.1128/msphere.00448-20 · Cited by 40
“In addition to keeping bacterial balance and preventing bacterial vaginosis (BV) and aerobic vaginitis (AV) (4), the vaginal microbiome has been shown to play a protective role against infections with viruses such as human papillomavirus (HPV) (5), herpes simplex virus 2 (HSV-2) (6), and human immunodeficiency virus (H…”
Metadata
- Authors
- Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G., & Hillier, S. L.
- Affiliations
- University of Pittsburgh (US)
- Magee-Womens Research Institute (US)
- Corresponding author
- Meyn, L. A.
- ORCID
- Krohn, M. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-01
- Volume
- 37
- Issue
- 3
- Pages
- 319-325
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2095874292
- Cited by
- 415
- References
- 31
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 14 · 2023: 17 · 2022: 23 · 2021: 15 · 2020: 24 · 2019: 22 · 2018: 23 · 2017: 27 · 2016: 22 · 2015: 20 · 2014: 21 · 2013: 28 · 2012: 16
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Washington
- U.S. Public Health Service (N01-A1-75326)
- National Institute of Allergy and Infectious Diseases (T32-AI07333, U01-AI46745, T32AI007333, U01AI046745)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- herpes simplex virus type 2, bacterial vaginosis, HSV-1 infection, Black women, educational attainment, new sexual partners, population attributable risk
- MeSH terms
- Adult, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Herpes Simplex, Humans, Longitudinal Studies, Pregnancy, Risk Factors, Cohort Studies, Polymerase Chain Reaction, Vaginosis, Bacterial, Herpesvirus 2, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.